Find your path to Aman
8 people in our graph share verified history with Aman — schools, employers, funds. One of them is your warm intro.
About
Aman Kant is the co-founder and President of Invea Therapeutics, where he leads corporate strategy, operations, and development execution, including financing, portfolio prioritization, translational strategy, clinical planning, partnerships, and investor engagement. He has worked at the intersection of biotechnology and artificial intelligence for nearly two decades, co-founding two companies that apply AI to drug discovery and development for immune-mediated inflammatory diseases and other complex conditions. His experience includes strategic alliances, technology licensing, and commercial agreements across pharmaceutical R&D.
Chief Operating Officer at Invea Therapeutics, Inc.
Intro paths
In turn, Aman can intro founders to Invea Therapeutics, Inc.'s investors below.
Invea Therapeutics, Inc.'s investors · 1
Co-founders at Invea Therapeutics, Inc.
Experience
- Invea TherapeuticsCo-founder and Presidentcurrent2025 — present
- Invea TherapeuticsCo-founder and Chief Operating Officer2024 — 2025Guilford, Connecticut, United States
- InveniAIChief Business Officer and Founding Member2017 — 2025Guilford, Connecticut, United States
- BioXcel CorporationVice President, Business Development & Alliances2015 — 2017New York City Metropolitan Area
- BioXcel CorporationDirector, Business Development & Alliance Management2011 — 2015
- BioXcel CorporationManager, Business Development2006 — 2011
Skills & more
+8 more
Marketing StrategyStart-upsStrategic PartnershipsFundraisingTechnology EvaluationGastrointestinal DisordersPortfolio OptimizationBusiness Portfolio ManagementLanguages Hindi
From Aman's professional profile.
Frequently asked questions
- Who is Aman Kant?
- Aman Kant is the co-founder and President of Invea Therapeutics, where he leads corporate strategy, operations, and development execution, including financing, portfolio prioritization, translational strategy, clinical planning, partnerships, and investor engagement. He has worked at the intersection of biotechnology and artificial intelligence for nearly two decades, co-founding two companies that apply AI to drug discovery and development for immune-mediated inflammatory diseases and other complex conditions. His experience includes strategic alliances, technology licensing, and commercial agreements across pharmaceutical R&D.
- Where does Aman Kant work?
- Aman Kant is Chief Operating Officer at Invea Therapeutics, Inc..
- Where did Aman Kant go to school?
- Aman Kant studied at Jaypee University of Information Technology (Bachelor of Technology - BTech, Biotechnology).
